Study action of homoeopathic remedy Justicia adhatoda in treatment of bacterial pneumonia in children aged 1-6 years when given with conventional treatment

Justicia adhatoda 30 a homoeopathic medicine as an adjuvant in pediatric bacterial pneumonia in the age group 1-6 years: A Randomized clinical study - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064538

Enrollment

Registered

2024-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J159- Unspecified bacterial pneumonia

Interventions

Intervention1: Justicia Adhatoda 30C: Potentised homoeopathic medicine Justicia Adhatoda 30C in the form of pills. Dose: Standard treatment and Justicia Adhatoda 30,3 pills thrice a day. Route of admi

Eligibility

Inclusion criteria

Inclusion criteria: Case definition: 1.All diagnosed cases of pediatric bacterial pneumonia 2.All age group 1 up to 6 years 3.Cough, fever and dyspnea 4.Respiratory rate of 40 or more than 40 per minute according to WHO classification of pediatric pneumonia 5.Lower chest indrawing, normal oxygen saturation (92-100%) according to WHO criteria for pediatric pneumonia 6.Changes in laboratory investigations of raised CRP, WBC, ESR and opacification seen in chest X-ray Other inclusion criteria apart from case definition 1. Patients will be taken irrespective of socioeconomic status 2. Patients whose parents are willing to give their consent 3.Children under allopathic treatment for bacterial pneumonia will be included

Exclusion criteria

Exclusion criteria: 1.Cases that do not fulfill the case definition 2.Patients with severe pneumonia according to WHO i.e lower chest indrawing, unable to breastfeed or drink, convulsions, lethargy, unconsciousness, severe respiratory distress, central cyanosis etc 3.Cases with chronic respiratory diseases like asthma, tuberculosis, bronchitis etc 4.Patients whose parents are not willing to give their consent 5.Mentally challenged patient will be excluded

Design outcomes

Primary

Measure	Time frame
To assess the duration and the intensity of symptoms using Diary Symptom Scoring by Likert scale after the medicine Justicia adhatoda has been given.Timepoint: The follow ups will be taken everyday for a period of 7 days by using Diary Symptom Scoring by Likert Scale after the medicine Justicia adhatota has been given.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Evangeline Snaitang

Bharati Vidyapeeth (Deemed to be University), Homoeopathic Medical College, Pune

swati.shinde@bharatividyapeeth.edu9890140393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026